Company / Net Income
Summit Therapeutics Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$1.1B
FY2025
5-year range
-$1.1B / -$88.6M
FY2021-FY2025
Trend
-387.8%
vs FY2024
Sector context
#210 of 216
Health Care
What the data says
Net Income changed -388% YoY in FY2025, a notable deviation from the 7-year average annual change of -205%.
Based on SEC 10-K filings.
-$1.1B in FY2025.
Declined from -$615M to -$1.1B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 216This company -$1.1B Sector average $454.3M
▼
-337.6% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 387.8% year-over-year.
- Ranks #210 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.1B | -387.8% |
| FY2024 | -$221.3M | +64.0% |
| FY2023 | -$614.9M | -594.0% |
| FY2022 | -$88.6M | +0.0% |
| FY2021 | -$88.6M | -68.1% |
| FY2020 | -$52.7M | -80.9% |
| FY2019 | -$29.1M | -368.0% |
| FY2018 | $10.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026